This page shows results related to Alaway and Mydriasis from the FDA Adverse Event Reporting System (AERS). The adverse event Mydriasis has been reported to the FDA a total of 8 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Mydriasis is 21. The chart below compares this proportional reporting ratio of Mydriasis for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Mydriasis.
| Mydriasis | |
| Alaway | 21 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Mydriasis, why were they taking Alaway?
| Eye Pruritus | 4 |
| Seasonal Allergy | 1 |
Which medications reported to the FDA are most commonly associated with Mydriasis?
| Opcon-a | 219 |
| Strattera | 183 |
| Pristiq | 112 |
| Citalopram Hydrobromide | 109 |
| Cymbalta | 98 |
| Lorazepam | 72 |
| Paroxetine Hcl | 72 |
| Effexor Xr | 66 |
| Oxycontin | 65 |
| Tramadol Hcl | 62 |
| Paxil | 60 |
 Show More |
